Literature DB >> 25572087

Cortical laminar binding of PET amyloid and tau tracers in Alzheimer disease.

Yi Li1, Wai Tsui2, Henry Rusinek2, Tracy Butler3, Lisa Mosconi2, Elizabeth Pirraglia2, David Mozley4, Shankar Vallabhajosula4, Ryuichi Harada5, Shozo Furumoto6, Katsutoshi Furukawa5, Hiroyuki Arai5, Yukitsuka Kudo5, Nobuyuki Okamura7, Mony J de Leon8.   

Abstract

UNLABELLED: Neurofibrillary tau pathology and amyloid β (Aβ) plaques, characteristic lesions of Alzheimer disease (AD), show different neocortical laminar distributions. Neurofibrillary-tangle tau pathology tends to be closer to the gray matter-white matter boundary, whereas Aβ is dispersed throughout the width of the cortical ribbon.
METHODS: Using PET radiotracers for tau and Aβ lesions, we developed an image analysis tool to measure the distance of tracer-positive voxels from the gray matter-white matter boundary. We studied 5 AD and 5 healthy subjects with both (18)F-THK5117 (tau) and (11)C-Pittsburgh compound B (Aβ) PET.
RESULTS: On average, tau-positive voxels were closer to the white matter than were Aβ-positive voxels. This effect was found for all AD subjects and for all regions, both before and after regionally adjusting for the nonspecific white matter binding of both tracers. The differential laminar pattern was validated through postmortem examination.
CONCLUSION: Within cortical lamina, distance measures may be of value in testing PET tracers for their anatomic selectivity.
© 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Entities:  

Keywords:  PET; amyloid beta; neocortical binding; tau

Mesh:

Substances:

Year:  2015        PMID: 25572087      PMCID: PMC4652320          DOI: 10.2967/jnumed.114.149229

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  12 in total

1.  Non-invasive assessment of Alzheimer's disease neurofibrillary pathology using 18F-THK5105 PET.

Authors:  Nobuyuki Okamura; Shozo Furumoto; Michelle T Fodero-Tavoletti; Rachel S Mulligan; Ryuichi Harada; Paul Yates; Svetlana Pejoska; Yukitsuka Kudo; Colin L Masters; Kazuhiko Yanai; Christopher C Rowe; Victor L Villemagne
Journal:  Brain       Date:  2014-03-27       Impact factor: 13.501

2.  Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease.

Authors:  B T Hyman; J Q Trojanowski
Journal:  J Neuropathol Exp Neurol       Date:  1997-10       Impact factor: 3.685

Review 3.  Chronic traumatic encephalopathy: neurodegeneration following repetitive concussive and subconcussive brain trauma.

Authors:  Christine M Baugh; Julie M Stamm; David O Riley; Brandon E Gavett; Martha E Shenton; Alexander Lin; Christopher J Nowinski; Robert C Cantu; Ann C McKee; Robert A Stern
Journal:  Brain Imaging Behav       Date:  2012-06       Impact factor: 3.978

4.  Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases.

Authors:  P R Hof; C Bouras; L Buée; A Delacourte; D P Perl; J H Morrison
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 5.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

6.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Authors:  William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

7.  Phases of A beta-deposition in the human brain and its relevance for the development of AD.

Authors:  Dietmar R Thal; Udo Rüb; Mario Orantes; Heiko Braak
Journal:  Neurology       Date:  2002-06-25       Impact factor: 9.910

8.  A 2-process model for neuropathology of Alzheimer's disease.

Authors:  Dan Mungas; Rochelle Tractenberg; Julie A Schneider; Paul K Crane; David A Bennett
Journal:  Neurobiol Aging       Date:  2013-09-27       Impact factor: 4.673

9.  Imaging beta-amyloid burden in aging and dementia.

Authors:  C C Rowe; S Ng; U Ackermann; S J Gong; K Pike; G Savage; T F Cowie; K L Dickinson; P Maruff; D Darby; C Smith; M Woodward; J Merory; H Tochon-Danguy; G O'Keefe; W E Klunk; C A Mathis; J C Price; C L Masters; V L Villemagne
Journal:  Neurology       Date:  2007-05-15       Impact factor: 9.910

10.  Early clinical PET imaging results with the novel PHF-tau radioligand [F18]-T808.

Authors:  David T Chien; A Katrin Szardenings; Shadfar Bahri; Joseph C Walsh; Fanrong Mu; Chunfang Xia; William R Shankle; Alan J Lerner; Min-Ying Su; Arkadij Elizarov; Hartmuth C Kolb
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

View more
  11 in total

Review 1.  Military-related risk factors for dementia.

Authors:  Heather M Snyder; Roxana O Carare; Steven T DeKosky; Mony J de Leon; Derek Dykxhoorn; Li Gan; Raquel Gardner; Sidney R Hinds; Michael Jaffee; Bruce T Lamb; Susan Landau; Geoff Manley; Ann McKee; Daniel Perl; Julie A Schneider; Michael Weiner; Cheryl Wellington; Kristine Yaffe; Lisa Bain; Anthony M Pacifico; Maria C Carrillo
Journal:  Alzheimers Dement       Date:  2018-11-08       Impact factor: 21.566

2.  Quantitative evaluation of tau PET tracers 18F-THK5351 and 18F-AV-1451 in Alzheimer's disease with standardized uptake value peak-alignment (SUVP) normalization.

Authors:  Jingyun Chen; Yi Li; Elizabeth Pirraglia; Nobuyuki Okamura; Henry Rusinek; Mony J de Leon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-27       Impact factor: 9.236

3.  Cerebrospinal Fluid Clearance in Alzheimer Disease Measured with Dynamic PET.

Authors:  Mony J de Leon; Yi Li; Nobuyuki Okamura; Wai H Tsui; Les A Saint-Louis; Lidia Glodzik; Ricardo S Osorio; Juan Fortea; Tracy Butler; Elizabeth Pirraglia; Silvia Fossati; Hee-Jin Kim; Roxana O Carare; Maiken Nedergaard; Helene Benveniste; Henry Rusinek
Journal:  J Nucl Med       Date:  2017-03-16       Impact factor: 10.057

4.  Lychee seed extract protects against neuronal injury and improves cognitive function in rats with type II diabetes mellitus with cognitive impairment.

Authors:  Yong Tang; Chonglin Yu; Jianming Wu; Haixia Chen; Yuan Zeng; Xiuling Wang; Le Yang; Qibing Mei; Shousong Cao; Dalian Qin
Journal:  Int J Mol Med       Date:  2017-11-09       Impact factor: 4.101

5.  Application of Haralick texture features in brain [18F]-florbetapir positron emission tomography without reference region normalization.

Authors:  Desmond L Campbell; Hakmook Kang; Sepideh Shokouhi
Journal:  Clin Interv Aging       Date:  2017-12-07       Impact factor: 4.458

Review 6.  Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective.

Authors:  Maria Ricci; Andrea Cimini; Riccardo Camedda; Agostino Chiaravalloti; Orazio Schillaci
Journal:  Int J Mol Sci       Date:  2021-11-30       Impact factor: 5.923

7.  Decreased CSF clearance and increased brain amyloid in Alzheimer's disease.

Authors:  Yi Li; Mony J de Leon; Henry Rusinek; Tracy Butler; Lidia Glodzik; Elizabeth Pirraglia; John Babich; P David Mozley; Sadek Nehmeh; Silky Pahlajani; Xiuyuan Wang; Emily B Tanzi; Liangdong Zhou; Sara Strauss; Roxana O Carare; Neil Theise; Nobuyuki Okamura
Journal:  Fluids Barriers CNS       Date:  2022-03-14

Review 8.  Insight into the Molecular Imaging of Alzheimer's Disease.

Authors:  Abishek Arora; Neeta Bhagat
Journal:  Int J Biomed Imaging       Date:  2016-01-10

Review 9.  The development and validation of tau PET tracers: current status and future directions.

Authors:  Nobuyuki Okamura; Ryuichi Harada; Aiko Ishiki; Akio Kikuchi; Tadaho Nakamura; Yukitsuka Kudo
Journal:  Clin Transl Imaging       Date:  2018-07-20

Review 10.  Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development.

Authors:  Stuart P McCluskey; Christophe Plisson; Eugenii A Rabiner; Oliver Howes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-21       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.